Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Valencia School of Medicine, Valencia, Spain. Jose.V.Bagan@uv.es
José
J
Bagán
Juan
J
Blade
Jose Manuel
JM
Cozar
Manuel
M
Constela
Ramón
R
García Sanz
Francisco
F
Gómez Veiga
Juan José
JJ
Lahuerta
Ana
A
Lluch
Bartomeu
B
Massuti
Juan
J
Morote
Jesús F
JF
San Miguel
Eduardo
E
Solsona
D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D017410:Practice Guidelines as Topic
D004164:Diphosphonates